1 |
Spiro RH : Salivary neoplasms, overview of a 35 year experience with 2,807 patients. Head Neck Surg 8 : 177, 1986
DOI
PUBMED
ScienceOn
|
2 |
Airoldi M, Fornari G, Pedani F et al : Paclitaxel and carboplatin for recurrent salivary gland malignancies. Anticancer Res 20(5C) : 3781, 2000
PUBMED
|
3 |
Holsinger FC, Doan DD, Jasser SA, et al. Epidermal growth factor receptor blockade potentiates apoptosis mediated by paclitaxel and leads to prolonged survival in a murine model of oral cancer. Clin Cancer Res 9 : 3183-9, 2003
PUBMED
|
4 |
Esser S, Wolburg K, Wolburg H et al : Vascular endothelial growth factor induces endothelial fenestrations in vitro. J Cell Biol 140 : 947, 1998
DOI
ScienceOn
|
5 |
Ferrara N, Houck K, Jakeman L et al : Molecular and biological properties of the vascular endothelial growth factor family of proteins. Endocr Rev 13 : 18, 1992
PUBMED
|
6 |
Sauter ER, Nesbit M, Watson JC, et al. Vascular endothelial growth factor is a marker of tumor invasion and metastasis in squamous cell carcinoma of the head and neck. Clin Cancer Res 1999; 5: 775-82
PUBMED
|
7 |
Killion JJ, Radinsky R, Fidler IJ : Orthotopic models are necessary to predict therapy of transplantable tumors in mice. Cancer Metas Rev 17 : 279, 1999
|
8 |
Spiro RH : Salivary neoplasms, overview of a 35 year experience with 2,807 patients. Head Neck Surg 8 : 177, 1986
DOI
PUBMED
ScienceOn
|
9 |
Herbst RS, Langer CJ : Epidermal growth factor receptors as a target for cancer treatment: the emerging role of IMC-C225 in the treatment of lung and head and neck cancers. Semin Oncol 29 : 27, 2002
PUBMED
|
10 |
Neuchrist C, Quint C, Pammer A et al : Vascular endothelial growth factor (VEGF) and microvessel density in squamous cell carcinomas of the larynx: an immunohistochemical study. Acta Otolaryngol 119 : 732, 1999
DOI
PUBMED
ScienceOn
|
11 |
Ishibashi H, Shiratuchi T, Nakagawa K et al : Hypoxiainduced angiogenesis of cultured human salivary gland carcinoma cells enhances vascular endothelial growth factor production and basic fibroblast growth factor release. Oral Oncol 37 : 77, 2001
DOI
ScienceOn
|
12 |
Bergers G, Brekken R, McMahon G et al : Matrix metalloproteinase- 9 triggers the angiogenic switch during carcinogenesis. Nat Cell Biol 2 : 737, 2000
DOI
ScienceOn
|
13 |
Craven RJ, Lightfoot H, Cance WG : A decade of tyrosine kinases: from gene discovery to therapeutics. Surg Oncol 12 : 39, 2003
DOI
ScienceOn
|
14 |
Cohen EE, Rosen F, Stadler WM et al : Phase II trial of ZD1839 in recurrent or metastatic squamous cell carcinoma of the head and neck. J Clin Oncol 21: 1980, 2003
DOI
ScienceOn
|
15 |
Luca M, Huang S, Gershenwald JE et al : Expression of interleukin-8 by human melanoma cells up-regulates MMP-2 activity and increases tumor growth and metastasis. Am J Pathol 151 : 41, 1997
|
16 |
Koch AE, Polverini PJ, Kunkel SL et al : Interleukin-8 as a macrophage derived mediator of angiogenesis. Science 258 : 1798, 1992
DOI
PUBMED
|
17 |
Khazaie K, Schirrmacher V, Lichtner RB : EGF receptor in neoplasia and metastasis. Cancer Metastasis Rev 12 : 255, 1993
DOI
ScienceOn
|
18 |
Radinsky R, Risin S, Fan D et al : Level and function of epidermal growth factor receptor predict the metastatic potential of human colon carcinoma cells. Clin Cancer Res 1 : 19, 1995
|
19 |
Kawashima M : Chemoradiotherapy for head and neck cancer: current status and perspectives. Int J Clin Oncol 9 : 421, 2004
DOI
ScienceOn
|
20 |
Yigitbasi OG, Younes MN, Doan D et al : Tumor cell and endothelial cell therapy of oral cancer by dual tyrosine kinase receptor blockade. Cancer Res 64 : 7977, 2004
DOI
ScienceOn
|
21 |
Baselga J, Rischin D, Ranson M et al : Phase I safety, pharmacokinetic, and pharmacodynamic trial of ZD1839, a selective oral epidermal growth factor receptor tyrosine kinase inhibitor, in patients with five selected solid tumor types. J Clin Oncol 20 : 4292, 2002
DOI
ScienceOn
|
22 |
Fordice J, Kershaw C, El-Naggar et al : Adenoid cystic carcinoma of the head and neck: predictors of morbidity and mortality. Arch Otolaryngol Head Neck Surg 125 : 149, 1999
PUBMED
|
23 |
Obermair A, Kohlberger P, Bancher-Todesca D et al : Influence of microvessel density and vascular permeability factor/ vascular endothelial growth factor expression on prognosis in vulvar cancer. Gynecol Oncol 63 : 204, 1996
DOI
ScienceOn
|
24 |
Chang C, Werb Z : The many faces of metalloproteases: cell growth, invasion, angiogenesis and metastasis. Trends in Cell Biol 11 : S37, 2001
|
25 |
Yu F, Jiang XZ, Chen WT et al : Microvessel density and expression of vascular endothelial growth factor in adenoid cystic carcinoma of salivary gland. Shanghai Kou Qiang Yi Xue 12 : 443, 2003
PUBMED
|
26 |
Kubota T : Metastatic models of human cancer xenografted in mice: the importance of orthotopic transplantation. J Cell Biochem 56 : 4, 1994
DOI
PUBMED
ScienceOn
|
27 |
Dong Z, Radinsky R, Fan D et al : Organ-specific modulation of steady-state mdr gene expression and drug resistance in murine colon carcinoma cell line. J Natl Cancer Inst 86 : 913, 1994
DOI
ScienceOn
|
28 |
Gille J, Swerlick RA, Caughman SW : Transforming growth factor-alpha-induced transcriptional activation of the vascular permeability factor (VPF/VEGF) gene requires AP-2-dependent DNA binding and transactivation. Embo J 16 : 750, 1997
DOI
PUBMED
ScienceOn
|
29 |
de Jong JS : Expression of growth factors, growth-inhibiting factors, and their receptors in invasive breast cancer. II: Correlations with proliferation and angiogenesis. J Pathol 184 : 53, 1998
DOI
ScienceOn
|
30 |
Barnes CJ, Bagheri-Yarmand R, Mandal M et al : Suppression of epidermal growth factor receptor, mitogenactivated protein kinase, and Pak1 pathway and invasiveness of human cutaneous squamous cancer cells by the tyrosine kinase inhibitor ZD1839 (Iressa). Mol Cancer Ther 2 : 345, 2003
PUBMED
|
31 |
Goldman CK : Epidermal growth factor stimulates vascular endothelial growth factor production by human malignant glioma cells: a model of glioblastoma multiforme pathophysiology. Mol Biol Cell 4 : 121, 1993
PUBMED
|
32 |
Rusch V : Overexpression of the epidermal growth factor receptor and its ligand transforming growth factor alpha is frequent in resectable non-small cell lung cancer but does not predict tumor progression. Clin Cancer Res 3 : 515, 1997
PUBMED
|
33 |
Fu XY, Theodorescu D, Kerbel RS et al : Extensive multiorgan metastasis following orthotopic implantation of histologically- intact human bladder carcinoma tissue in nude mice. Int J Cancer 49 : 938, 1991
DOI
PUBMED
|
34 |
Vered M, Braunstein E, Buchner A : Immunohistochemical study of epidermal growth factor receptor in adenoid cystic carcinoma of salivary gland origin. Head Neck 24 : 632, 2002
DOI
ScienceOn
|
35 |
Fidler IJ, Wilmanns C, Staroselsky A et al : Modulation of tumor cell reponse to chemotherapy by the organ environment. Cancer Metastasis Rev 13 : 209, 1994
DOI
ScienceOn
|
36 |
Ang KK, Andratschke NH, Milas L : Epidermal growth factor receptor and response of head-and-neck carcinoma to therapy. Int J Radiat Oncol Biol Phys 58 : 959, 2004
DOI
ScienceOn
|
37 |
Bowden J, Brennan PA, Umar T et al : Expression of vascular endothelial growth factor in basal cell carcinoma and cutaneous squamous cell carcinoma of the head and neck. J Cutan Pathol 29 : 585, 2002
DOI
ScienceOn
|
38 |
Fidler IJ : Rationale and methods for the use of nude mice to study the biology and therapy of human cancer metastasis. Cancer Metastasis Rev 5 : 29, 1986
DOI
ScienceOn
|